Add To Watchlist
Share URL
About The Company
CEO
Ms. Dominique Rmy-Renou
Market Cap
2.48 Million EUR
Sector
Healthcare
Website
https://www.genomicvision.comDescription
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France.
Read More
Overview
Value
1
Growth
62
Health
23
Management
60
Analyst Opinion
63
Total
42
All Scores Out Of 100
Best Features
- Very strong cashflow and earnings growth
- Earnings growth has improved recently
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- Altman-Z score suggests a risk of bankruptcy
- Poor overall financial health
- No margin of safety at their current market price
- Cashflow is growing faster than revenue
Market Peers
GV.PA
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-156.81%
Revenue Growth (5 Year Average)
12.23%
Ratings Consensus
Neutral
Share Buybacks
-80.93%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✘
Current Price: 0 EUR
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-179.81%
PE/Earnings Growth
N/A
Price/Book
6.08x
Growth
Growth Score
62
- ✔ 5 Year Average Revenue growth of 12.23% is higher than the market average (10.97%)
- ✔ 5 Year Average Earnings growth of 21.41% is higher than the market average (14.48%)
- ✔ Earnings growth has improved this year
- ✔ Free Cashflow growth has improved this year
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of 13.17% is lower than the market average (12.35%)
Revenue Growth
12.23%
Earnings Growth
21.41%
Cashflow Growth
13.17%
Health
Health Score
23
Altman Z Score
-3.31
Piostroski Score
1.00
Debt/Equity
0.32x
Current Assets/Liabilities
2.01x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.19x
Management
Management Score
60
Average Buybacks/Dilution
-80.93%
Recent Buybacks/Dilution
97.54%
5 Year Price Volitility
95.34%
Return On Assets
-146.66%
Return On Capital Employed
-47.19%
Return On Equity
-323.58%
Return On Free Cashflow
260.71%
Return On Investments
N/A
Analysts
Analyst Opinion
63
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Genomic Vision Société Anonyme
Currency
EUR
Beta
-0.294901
Vol Avg
2709759
Ceo
Ms. Dominique Rmy-Renou
Cik
Cusip
Exchange
Paris
Full Time Employees
33
Industry
Diagnostics & Research
Sector
Healthcare
Ipo Date
2014-04-02
Address
Green Square Batiment E, 80-84 rue des Meuniers
City
Bagneux
State
ILE-DE-FRANCE
Country
FR
Zip
92220
Phone
33149080740
All financial data provided by FMP